K.N.Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.05 Cr
as on 17-12-2024
- Company Age 37 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.64 M
as on 17-12-2024
- Satisfied Charges ₹ 2.21 M
as on 17-12-2024
- Revenue 15.75%
(FY 2020)
- Profit 2075.38%
(FY 2020)
- Ebitda 156.59%
(FY 2020)
- Net Worth 821.37%
(FY 2020)
- Total Assets 41.97%
(FY 2020)
About K.N.Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.05 Cr.
The company currently has active open charges totaling ₹2.64 M. The company has closed loans amounting to ₹2.21 M, as per Ministry of Corporate Affairs (MCA) records.
Rangarao Kakarala, Pardha Kommana, and Vijaya Kakarala serve as directors at the Company.
- CIN/LLPIN
U24230TG1987PTC007718
- Company No.
007718
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationHyd., Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at K.N.Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rangarao Kakarala  | Managing Director | 24-Aug-1987 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pardha Kommana | Director | 29-Sep-2005 | Current |
| Vijaya Kakarala | Whole-Time Director | 05-Sep-2001 | Current |
Financial Performance and Corporate Structure Insights of K.N.Biotech.
K.N.Biotech Pvt Ltd, for the financial year ended 2020, experienced significant growth in revenue, with a 15.75% increase. The company also saw a substantial improvement in profitability, with a 2075.38% increase in profit. The company's net worth Soared by an impressive increase of 821.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of K.N.Biotech?
In 2018, K.N.Biotech had a promoter holding of 23.20% and a public holding of 76.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 22 May 2002 | ₹2.00 M | Open |
State Bank Of India Creation Date: 27 Jul 1989 | ₹0.64 M | Open |
Andhra Pradesh State Financial Corporation Creation Date: 29 Dec 1989 | ₹0.29 M | Satisfied |
How Many Employees Work at K.N.Biotech?
K.N.Biotech has a workforce of 2 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K.N.Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K.N.Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
